WHITEHAWK THERAPEUTICS, INC. Increase Decrease In Operating Lease Liability
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Increase Decrease In Operating Lease Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was $0.00.
- WHITEHAWK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2025 was -$89.00K.
- WHITEHAWK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$512.00K.
- WHITEHAWK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$502.00K.
- WHITEHAWK THERAPEUTICS, INC. increase decrease in operating lease liability for fiscal 2022 was -$291.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | -$89.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | -$89.00K 10-Q · filed 2025-11-06 | -$218.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$89.00K 10-Q · filed 2026-08-06 | -$218.00K derived: sum of 3 quarters · filed 2026-08-06 | -$347.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$89.00K 10-Q · filed 2026-05-07 | -$218.00K derived: sum of 2 quarters · filed 2026-05-07 | -$347.00K derived: sum of 3 quarters · filed 2026-05-07 | -$475.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$258.00K derived: sum of 2 quarters · filed 2026-03-12 | -$386.00K derived: sum of 3 quarters · filed 2026-03-12 | -$512.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$257.00K derived: sum of 2 quarters · filed 2025-11-06 | -$383.00K 10-Q · filed 2025-11-06 | -$510.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$254.00K 10-Q · filed 2025-08-07 | -$381.00K derived: sum of 3 quarters · filed 2025-08-07 | -$506.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$126.00K 10-Q · filed 2025-05-08 | -$253.00K derived: sum of 2 quarters · filed 2025-05-08 | -$378.00K derived: sum of 3 quarters · filed 2025-05-08 | -$504.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$252.00K derived: sum of 2 quarters · filed 2025-03-28 | -$378.00K derived: sum of 3 quarters · filed 2025-03-28 | -$502.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$251.00K derived: sum of 2 quarters · filed 2024-11-06 | -$375.00K 10-Q · filed 2024-11-06 | -$496.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$250.00K 10-Q · filed 2024-08-07 | -$371.00K derived: sum of 3 quarters · filed 2024-08-07 | -$451.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$124.00K 10-Q · filed 2024-05-08 | -$245.00K derived: sum of 2 quarters · filed 2024-05-08 | -$325.00K derived: sum of 3 quarters · filed 2024-05-08 | -$371.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$201.00K derived: sum of 2 quarters · filed 2024-03-13 | -$247.00K derived: sum of 3 quarters · filed 2024-03-13 | -$291.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$126.00K derived: sum of 2 quarters · filed 2023-11-08 | -$170.00K 10-Q · filed 2023-11-08 | -$178.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$90.00K 10-Q · filed 2023-08-09 | -$98.00K derived: sum of 3 quarters · filed 2023-08-09 | -$131.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$44.00K 10-Q · filed 2023-05-10 | -$52.00K derived: sum of 2 quarters · filed 2023-05-10 | -$85.00K derived: sum of 3 quarters · filed 2023-05-10 | -$121.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$41.00K derived: sum of 2 quarters · filed 2023-03-29 | -$77.00K derived: sum of 3 quarters · filed 2023-03-29 | -$129.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$69.00K derived: sum of 2 quarters · filed 2022-11-09 | -$121.00K 10-Q · filed 2022-11-09 | -$172.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$88.00K 10-Q · filed 2022-08-10 | -$139.00K derived: sum of 3 quarters · filed 2022-08-10 | |
| 2021-03-31 | -$52.00K 10-Q · filed 2022-05-12 | -$103.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$197.00K 10-K · filed 2022-03-17 | ||
| 2020-09-30 | -$146.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |